Rapid Micro Biosystems, INC 10-Q quarterly reports

Rapid Micro Biosystems reported increased revenue for the quarter ended June 30, 2026, but also a widening net loss, with operating expenses rising across the board.

Rapid Micro Biosystems, Inc. reported an 11.1% increase in total revenue for the first quarter of 2026, reaching $8.0 million, despite a wider net loss.

Rapid Micro Biosystems reports improved nine-month financial performance with reduced net losses and increased revenue, driven by recurring sales and a new debt facility.

Rapid Micro Biosystems reports increased revenue and improved gross margins in Q2 2025, securing a new $45 million debt facility to bolster liquidity despite continued net losses.

Rapid Micro Biosystems reports a 28.4% increase in revenue for Q1 2025, driven by service revenue growth and cost reduction initiatives, while still operating at a net loss.

Rapid Micro Biosystems announced its Q3 2024 results, highlighting revenue growth and the implementation of an operational efficiency program aimed at achieving positive cash flow by the end of 2027.

Rapid Micro Biosystems announced its second quarter 2024 results, highlighting revenue growth and the implementation of a cost-cutting program aimed at achieving positive cash flow by the end of 2027.

Rapid Micro Biosystems reports an 11.4% increase in revenue for the first quarter of 2024, driven by growth in both product and service revenue.